Literature DB >> 25636764

Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.

Yoonsun Chung1, Jun Won Kim2, Kyung Hwan Shin3, Su Ssan Kim4, Sung-Ja Ahn5, Won Park6, Hyung-Sik Lee7, Dong Won Kim8, Kyu Chan Lee9, Hyun Suk Suh10, Jin Hee Kim11, Hyun Soo Shin12, Yong Bae Kim13, Chang-Ok Suh1.   

Abstract

PURPOSE: The Korean Radiation Oncology Group (KROG) 08-06 study protocol allowed radiation therapy (RT) technique to include or exclude breast cancer patients from receiving radiation therapy to the internal mammary lymph node (IMN). The purpose of this study was to assess dosimetric differences between the 2 groups and potential influence on clinical outcome by a dummy run procedure. METHODS AND MATERIALS: All participating institutions were asked to produce RT plans without irradiation (Arm 1) and with irradiation to the IMN (Arm 2) for 1 breast-conservation treatment case (breast-conserving surgery [BCS]) and 1 mastectomy case (modified radical mastectomy [MRM]) whose computed tomography images were provided. We assessed interinstitutional variations in IMN delineation and evaluated the dose-volume histograms of the IMN and normal organs. A reference IMN was delineated by an expert panel group based on the study guidelines. Also, we analyzed the potential influence of actual dose variation observed in this study on patient survival.
RESULTS: Although physicians intended to exclude the IMN within the RT field, the data showed almost 59.0% of the prescribed dose was delivered to the IMN in Arm 1. However, the mean doses covering the IMN in Arm 1 and Arm 2 were significantly different for both cases (P<.001). Due to the probability of overdose in Arm 1, the estimated gain in 7-year disease-free survival rate would be reduced from 10% to 7.9% for BCS cases and 7.1% for MRM cases. The radiation doses to the ipsilateral lung, heart, and coronary artery were lower in Arm 1 than in Arm 2.
CONCLUSIONS: Although this dummy run study indicated that a substantial dose was delivered to the IMN, even in the nonirradiation group, the dose differences between the 2 groups were statistically significant. However, this dosimetric profile should be studied further with actual patient samples and be taken into consideration when analyzing clinical outcomes according to IMN irradiation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25636764     DOI: 10.1016/j.ijrobp.2014.10.022

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes.

Authors:  Sang-Won Kim; Doo Ho Choi; Seung Jae Huh; Won Park; Seok Jin Nam; Seok Won Kim; Jeong Eon Lee; Young-Hyuck Im; Jin Seok Ahn; Yeon Hee Park
Journal:  J Breast Cancer       Date:  2016-06-24       Impact factor: 3.588

2.  Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy.

Authors:  Ji Hyun Chang; Wan Jeon; Kyubo Kim; Kyung Hwan Shin; Wonshik Han; Dong-Young Noh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

3.  Postmastectomy radiotherapy using three different techniques: a retrospective evaluation of the incidental dose distribution in the internal mammary nodes.

Authors:  Wei Wang; Yingjie Zhang; Min Xu; Qian Shao; Tao Sun; Ting Yu; Xijun Liu; Jianbin Li
Journal:  Cancer Manag Res       Date:  2019-01-30       Impact factor: 3.989

4.  Factors Influencing the Incidental Dose Distribution in Internal Mammary Nodes: A Comparative Study.

Authors:  Wei Wang; Jinzhi Wang; Pengfei Qiu; Tao Sun; Yingjie Zhang; Qian Shao; Min Xu; Xijun Liu; Jianbin Li
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

5.  POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.

Authors:  Xu-Ran Zhao; Hui Fang; Yu Tang; Zhi-Hui Hu; Hao Jing; Lin Liang; Xue-Na Yan; Yong-Wen Song; Jing Jin; Yue-Ping Liu; Bo Chen; Yuan Tang; Shu-Nan Qi; Ning Li; Ning-Ning Lu; Kuo Men; Chen Hu; Yu-Hui Zhang; Ye-Xiong Li; Shu-Lian Wang
Journal:  BMC Cancer       Date:  2021-11-06       Impact factor: 4.430

6.  Dosimetric Evaluation of Incidental Irradiation to the Internal Mammary Chain After Surgery in Breast Cancer Patients.

Authors:  Wei Wang; Tao Sun; Yingtao Meng; Min Xu; Yingjie Zhang; Qian Shao; Yuanfang Song; Jianbin Li
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.